Market Cap

Ocuphire Pharma, Inc. Market Capitalization:

$50.8 Million

USD as of Jan. 1, 2026

business Ocuphire Pharma, Inc. Company Profile

Ocuphire Pharma, Inc. Main Stock Listing

NASDAQ: OCUP

Market Capitalization History of Ocuphire Pharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Ocuphire Pharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $50.8 M 60.17%
Jan. 1, 2025 $31.7 M -53.58%
Jan. 1, 2024 $68.4 M -15.10%
Jan. 1, 2023 $80.5 M 21.45%
Jan. 1, 2022 $66.3 M -72.84%
Jan. 1, 2021 $244.1 M 42.32%
Jan. 1, 2020 $171.5 M -73.31%
Jan. 1, 2019 $642.5 M -69.38%
Jan. 1, 2018 $2.10 B 22.94%
Jan. 1, 2017 $1.71 B -52.78%
Jan. 1, 2016 $3.61 B -50.68%
Jan. 1, 2015 $7.33 B -36.52%
Jan. 1, 2014 $11.55 B 259.37%
Jan. 1, 2013 $3.21 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Ocuphire Pharma, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Ocuphire Pharma, Inc. has the following listings and related stock indices.


Stock: NASDAQ: OCUP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.